https://bvt2733inhibitor.com/d....etermining-a-worldwi
The overall survival rates of patients with previously extensively treated diffuse large B-cell lymphoma have been positively impacted by the introduction of chimeric antigen receptor (CAR) T-cell treatment. Yet, the life-endangering side effects of CAR T-cells, coupled with early tumor relapses, persist as a critical challenge. Radiotherapy (RT) combined with CAR T-cells, according to smaller monocentric analyses, may indu
Gefällt mir
Kommentar
Teilen
